Interferon-a drives peripheral activation and brain injury in chronic HIV
干扰素-a 促进慢性 HIV 患者的外周激活和脑损伤
基本信息
- 批准号:8329279
- 负责人:
- 金额:$ 34.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-18 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdherenceBrainBrain InjuriesCD14 geneCellsChemotaxisChronicComorbidityDataDiseaseDisease ProgressionFCGR3B geneFrequenciesGene Expression ProfileHIVHIV InfectionsHumanImmuneImmune responseImpaired cognitionIn VitroIndividualInflammationInflammatory ResponseInterferon ActivationInterferon-alphaInterferonsLinkLipopolysaccharidesMacacaMinocyclineModelingN-acetylaspartateNervous System TraumaNeuraxisNeuronal DysfunctionNeuropathogenesisPeripheralPhenotypePopulationProteinsQuality of lifeRegulationResearchRiskRoleSIVSpleenT-LymphocyteViral Load resultantiretroviral therapychemokinecytokineimmune activationmonocytenervous system disorderresearch studyresponsewhite matter
项目摘要
DESCRIPTION (provided by applicant): There is substantial evidence that immune activation is the determining factor for disease progression and co-morbidities in HIV infection. Peripheral immune activation, which is triggered by HIV, impacts the function of T cells and monocytes. HIV-induced monocyte proteins have been investigated as markers of an activated state that is tied to neuropathogenesis in the CNS. This is supported by SIV macaque models pointing to immune responses in the periphery being linked to CNS damage. In humans, an activated peripheral monocyte phenotype correlates with lower N-acetylaspartate (NAA), which is linked to neuronal dysfunction. However, there remains considerable debate whether LPS, type 1 interferon (IFN) or other factors are the causative agents. Our research shows that monocytes from HIV-infected subjects have a type 1 IFN gene expression profile. It is our overall hypothesis that in HIV disease type 1 IFN is responsible for chronic immune activation, which is associated with disease progression including cognitive impairment. We will: 1) investigate a number of variables that could produce the IFN-induced monocyte phenotype, 2) define a new IFN- induced monocyte phenotype, CD169, 3) determine the impact of immune activation on chemotaxis and cytokine elaboration and 4) determine if monocyte activation enhances LPS tolerance. Understanding the mechanism for continued activation in chronically HIV-infected individuals is crucial for mitigating CNS damage.
PUBLIC HEALTH RELEVANCE: In spite of availability, adherence and effective antiretroviral therapy, there are still individuals who carry an HIV detectable viral load as well as those who are treated with no detectable viral load and have HIV-associated neurological disorders (HAND). We will show that continued peripheral activation by IFN-? is detrimental to HIV-infected individuals. We will investigate several mechanisms to suppress activation including compounds directed against peripheral markers of activation and inflammation.
描述(由申请人提供):有大量证据表明免疫激活是HIV感染中疾病进展和合并症的决定因素。由HIV触发的外周免疫激活影响T细胞和单核细胞的功能。hiv诱导的单核细胞蛋白已被研究作为与中枢神经系统神经发病机制相关的激活状态的标记物。SIV猕猴模型支持这一观点,表明外周免疫反应与中枢神经系统损伤有关。在人类中,激活的外周单核细胞表型与较低的n -乙酰天冬氨酸(NAA)相关,这与神经元功能障碍有关。然而,脂多糖、1型干扰素(IFN)或其他因素是否为致病因子仍存在相当大的争议。我们的研究表明,来自hiv感染者的单核细胞具有1型IFN基因表达谱。我们的总体假设是,在HIV疾病1型中,IFN负责慢性免疫激活,这与包括认知障碍在内的疾病进展有关。我们将:1)研究一些可能产生IFN诱导的单核细胞表型的变量,2)定义一个新的IFN诱导的单核细胞表型,CD169, 3)确定免疫激活对趋化性和细胞因子细化的影响,4)确定单核细胞激活是否增强LPS耐受性。了解慢性hiv感染者持续激活的机制对于减轻中枢神经系统损伤至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lynn PULLIAM其他文献
Lynn PULLIAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lynn PULLIAM', 18)}}的其他基金
ShEEP Request for Particle Matrix ZetaView
ShEEP 请求粒子矩阵 ZetaView
- 批准号:
10741098 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment
血浆神经元来源的外泌体是 HIV 认知障碍的生物标志物
- 批准号:
10577822 - 财政年份:2020
- 资助金额:
$ 34.2万 - 项目类别:
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment
血浆神经元来源的外泌体是 HIV 认知障碍的生物标志物
- 批准号:
10162665 - 财政年份:2020
- 资助金额:
$ 34.2万 - 项目类别:
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment
血浆神经元来源的外泌体是 HIV 认知障碍的生物标志物
- 批准号:
10393055 - 财政年份:2020
- 资助金额:
$ 34.2万 - 项目类别:
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment
血浆神经元来源的外泌体是 HIV 认知障碍的生物标志物
- 批准号:
9927404 - 财政年份:2020
- 资助金额:
$ 34.2万 - 项目类别:
Exosomes from HIV-activated monocytes induce endothelial cell activation
来自 HIV 激活的单核细胞的外泌体诱导内皮细胞激活
- 批准号:
8992717 - 财政年份:2015
- 资助金额:
$ 34.2万 - 项目类别:
Interferon-a drives peripheral activation and brain injury in chronic HIV
干扰素-a 促进慢性 HIV 患者的外周激活和脑损伤
- 批准号:
8513414 - 财政年份:2012
- 资助金额:
$ 34.2万 - 项目类别:
Interferon-a drives peripheral activation and brain injury in chronic HIV
干扰素-a 促进慢性 HIV 患者的外周激活和脑损伤
- 批准号:
8658709 - 财政年份:2012
- 资助金额:
$ 34.2万 - 项目类别:
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients
丙型肝炎导致 HIV/HCV 合并感染患者的神经发病机制
- 批准号:
7860629 - 财政年份:2009
- 资助金额:
$ 34.2万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Fellowship Programs